Data / Form D filings / NextPoint Therapeutics, Inc.
NextPoint Therapeutics, Inc.: Form D filings
NextPoint Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed 3 Form D notices with the SEC between 2022 and 2026. The latest, on July 30, 2026, reports $33.7 million sold of a $48.7 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 238 MAIN STREET, Cambridge, MA, 02142
- Phone
- (508) 204-1115
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1959209
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | New notice | $48,729,165 | $33,728,772 | $15,000,393 | 15 | Jul 22, 2026 | sec.gov |
| Feb 14, 2024 | New notice | $42,479,388 | $42,479,388 | 15 | Jan 31, 2024 | sec.gov | |
| Dec 27, 2022 | New notice | $79,999,992 | $79,999,992 | 13 | Dec 13, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Detlev Biniszkiewicz | Director | |
| Ivan Cheung | Executive Officer, Director | |
| Axel Hoos | Director | |
| R. Jacob Vogelstein | Director | |
| Brian Shuster | Director | |
| Paulina Hill | Director | |
| Rakhshita Dhar | Director | |
| Jeffrey Lacey | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 27, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NextPoint Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.